RxDoctor Payments Data

Donna Frazier, NP

Family · Columbia, MONPI 1487147369

Payments from drug & device makers

$506in general payments, 2019–2025

Across 27 payments — averaging $18.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$87
  • Johnson & Johnson$58
  • Ferring Pharmaceuticals Inc.$58
  • Accord Healthcare, Inc.$52
  • Urogen Pharma, Inc.$51
  • Tolmar, Inc.$46
  • plus $154 from 8 others

What the payments were for

  • Food & beverage$506100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$506 in reported general payments places this provider in the 55th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$65,028
Medicare patients
484
Services billed
2,450

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron44$27,079
MyrbetriqMirabegron14$8,972
Tamsulosin Hcl155$2,323
Solifenacin Succinate16$2,085
Testosterone Cypionate59$1,363
Testosterone13$1,242
Finasteride83$1,168
Oxybutynin Chloride ErOxybutynin Chloride35$929
Methenamine Hippurate11$876
Cephalexin40$321
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst13$301
Albuterol Sulfate HfaAlbuterol Sulfate12$253
Oxybutynin Chloride11$193
Doxycycline Hyclate30$189
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav15$128

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$87$27,07944 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,812 family providers in Missouri.

Other family in Columbia

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →